Drug-Induced hypothermia in stroke models: Does it always protect?

CNS and Neurological Disorders - Drug Targets

Volumn 12, Issue 3, 2013, Pages 371-380

  Zhang, Meijuan ^a,c   Wang, Haiying ^a,b   Zhao, Jinbing ^d   Chen, Cong ^c   Leak, Rehana K ^e   Xu, Yun ^c   Vosler, Peter ^a,b   Chen, Jun ^a,b   Gao, Yanqin ^b   Zhang, Feng ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b FUDAN UNIVERSITY   (China)

^c THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^d THE AFFILIATED BRAIN HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^e DUQUESNE UNIVERSITY   (United States)

Author keywords

Brain ischemia; Hypothermic; Neuroprotection; Pharmacological cooling

Indexed keywords

2, 3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL) PYRROLO [1, 2, 3 DE] [1, 4] BENZOXAZINE; 201; 3 IODOTHYRONAMINE; ABS 201; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; APOMORPHINE; BROMOCRIPTINE; CANNABINOID 1 RECEPTOR AGONIST; DOPAMINE RECEPTOR STIMULATING AGENT; ENKEPHALIN [2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; HALOPERIDOL; HYDROGEN SULFIDE; IDAZOXAN; NEUROTENSIN RECEPTOR ANTAGONIST; OPIATE RECEPTOR; PROPYLNORAPOMORPHINE; QUINPIROLE; RIMONABANT; RINVANIL; SEVOFLURANE; SULPIRIDE; TALIPEXOLE; THYROXINE DERIVATIVE; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR AFFECTING AGENT; WIN 55 212 2; YOHIMBINE;

ARTERIAL PRESSURE; ARTICLE; BODY TEMPERATURE; BRAIN INJURY; CARDIOVASCULAR FUNCTION; CEREBROVASCULAR ACCIDENT; CONTINUOUS INFUSION; COOLING; GENE EXPRESSION; HEART ARRHYTHMIA; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOTENSION; HYPOTHERMIA; HYPOXIC ISCHEMIC ENCEPHALOPATHY; ISCHEMIA; NEUROPROTECTION; NONHUMAN; PROTEIN PHOSPHORYLATION; SIDE EFFECT; TACHYCARDIA; THERMOREGULATION; VASODILATATION;

ANIMALS; HUMANS; HYPOTHERMIA, INDUCED; NEUROPROTECTIVE AGENTS; STROKE;

EID: 84878668164     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/1871527311312030010     Document Type: Article

References (132)

1. Yenari, M.A.; Hemmen, T.M. Therapeutic hypothermia for brain ischemia: where have we come and where do we go? Stroke, 2010, 41(10 Suppl), S72-S74.
2. Polderman, K.H.; Herold, I. Therapeutic hypothermia and controlled normothermia in the intensive care unit: practical considerations, side effects, and cooling methods. Crit. Care Med., 2009, 37(3), 1101-1120.
3. Olsen, T.S.; Weber, U.J.; Kammersgaard, L.P. Therapeutic hypothermia for acute stroke. Lancet Neurol., 2003, 2(7), 410-416.
4. Kollmar, R.; Staykov, D.; Dorfler, A.; Schellinger, P.D.; Schwab, S.; Bardutzky, J. Hypothermia reduces perihemorrhagic edema after intracerebral hemorrhage. Stroke, 2010, 41(8), 1684-1689.
5. Abdullah, J.M.; Husin, A. Intravascular hypothermia for acute hemorrhagic stroke: a pilot study. Acta Neurochir. Suppl., 2011, 111, 421-424.
6. Torok, E.; Klopotowski, M.; Trabold, R.; Thal, S.C.; Plesnila, N.; Scholler, K. Mild hypothermia (33 degrees C) reduces intracranial hypertension and improves functional outcome after subarachnoid hemorrhage in rats. Neurosurgery, 2009, 65(2), 352-359; discussion 359.
7. Fingas, M.; Penner, M.; Silasi, G.; Colbourne, F. Treatment of intracerebral hemorrhage in rats with 12 h, 3 days and 6 days of selective brain hypothermia. Exp. Neurol., 2009, 219(1), 156-162.
8. van der Worp, H.B.; Sena, E.S.; Donnan, G.A.; Howells, D.W.; Macleod, M.R. Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis. Brain, 2007, 130(Pt 12), 3063-3074.
9. van der Worp, H.B.; Macleod, M.R.; Kollmar, R. Therapeutic hypothermia for acute ischemic stroke: ready to start large randomized trials? J. Cereb. Blood Flow Metab., 2010, 30(6), 1079-1093.
10. Jacobs, S.; Hunt, R.; Tarnow-Mordi, W.; Inder, T.; Davis, P. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst. Rev., 2007, (4), CD003311.
11. Yager, J.Y.; Asselin, J. Effect of Mild Hypothermia on Cerebral Energy Metabolism during the evolution of hypoxic-ischemic brain damage in the immature rat. Stroke, 1996, 27(5), 919-926.
12. Choi, K.E.; Hall, C.L.; Sun, J.M.; Wei, L.; Mohamad, O.; Dix, T.A.; Yu, S.P. A novel stroke therapy of pharmacologically induced hypothermia after focal cerebral ischemia in mice. FASEB J., 2012, 26(7), 2799-2810.
13. Yenari, M.A.; Han, H.S. Neuroprotective mechanisms of hypothermia in brain ischaemia. Nat. Rev. Neurosci., 2012, 13(4), 267-278.
14. Miyazawa, T.; Tamura, A.; Fukui, S.; Hossmann, K.A. Effect of mild hypothermia on focal cerebral ischemia. Review of experimental studies. Neurol. Res., 2003, 25(5), 457-464.
15. Yenari, M.A.; Iwayama, S.; Cheng, D.; Sun, G.H.; Fujimura, M.; Morita-Fujimura, Y.; Chan, P.H.; Steinberg, G.K. Mild hypothermia attenuates cytochrome c release but does not alter Bcl-2 expression or caspase activation after experimental stroke. J. Cereb. Blood Flow Metab., 2002, 22(1), 29-38.
16. Erecinska, M.; Thoresen, M.; Silver, I.A. Effects of hypothermia on energy metabolism in Mammalian central nervous system. J. Cereb. Blood Flow Metab., 2003, 23(5), 513-530.
17. Bonifacio, S.L.; Saporta, A.; Glass, H.C.; Lee, P.; Glidden, D.V.; Ferriero, D.M.; Barkovich, A.J.; Xu, D. Therapeutic hypothermia for neonatal encephalopathy results in improved microstructure and metabolism in the deep gray nuclei. AJNR Am. J. Neuroradiol., 2012.
18. Cheng, G.; Sun, J.; Wang, L.; Shao, X.; Zhou, W. Effects of selective head cooling on cerebral blood flow and metabolism in newborn piglets after hypoxia-ischemia. Early Hum. Dev., 2011, 87(2), 109-114.
19. Baumann, E.; Preston, E.; Slinn, J.; Stanimirovic, D. Post-ischemic hypothermia attenuates loss of the vascular basement membrane proteins, agrin and SPARC, and the blood-brain barrier disruption after global cerebral ischemia. Brain Res., 2009, 1269, 185-197.
20. Duz, B.; Oztas, E.; Erginay, T.; Erdogan, E.; Gonul, E. The effect of moderate hypothermia in acute ischemic stroke on pericyte migration: an ultrastructural study. Cryobiology, 2007, 55(3), 279-284.
21. Choi, H.A.; Badjatia, N.; Mayer, S.A. Hypothermia for acute brain injury--mechanisms and practical aspects. Nat. Rev. Neurol., 2012, 8(4), 214-222.
22. Faridar, A.; Bershad, E.M.; Emiru, T.; Iaizzo, P.A.; Suarez, J.I.; Divani, A.A. Therapeutic hypothermia in stroke and traumatic brain injury. Front. Neurol., 2011, 2, 80.
23. Chen, H.; Chopp, M.; Zhang, Z.G.; Garcia, J.H. The effect of hypothermia on transient middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab., 1992, 12(4), 621-628.
24. Maier, C.M.; Ahern, K.v.; Cheng, M.L.; Lee, J.E.; Yenari, M.A.; Steinberg, G.K.; Kirsch, J.R. Optimal depth and duration of mild hypothermia in a focal model of transient cerebral ischemia: effects on neurologic outcome, infarct size, apoptosis, and inflammation • editorial comment: effects on neurologic outcome, infarct size, apoptosis, and inflammation. Stroke, 1998, 29(10), 2171-2180.
25. Testori, C.; Sterz, F.; Behringer, W.; Spiel, A.; Firbas, C.; Jilma, B. Surface cooling for induction of mild hypothermia in conscious healthy volunteers-a feasibility trial. Crit. Care, 2011, 15(5), R248.
26. Guluma, K.Z.; Oh, H.; Yu, S.W.; Meyer, B.C.; Rapp, K.; Lyden, P.D. Effect of endovascular hypothermia on acute ischemic edema: morphometric analysis of the ICTuS trial. Neurocrit. Care, 2008, 8(1), 42-47.
27. Hinz, J.; Rosmus, M.; Popov, A.; Moerer, O.; Frerichs, I.; Quintel, M. Effectiveness of an intravascular cooling method compared with a conventional cooling technique in neurologic patients. J. Neurosurg. Anesthesiol., 2007, 19(2), 130-135.
28. Groysman, L.I.; Emanuel, B.A.; Kim-Tenser, M.A.; Sung, G.Y.; Mack, W.J. Therapeutic hypothermia in acute ischemic stroke. Neurosurg. Focus., 2011, 30(6), E17.
29. Bouma, H.R.; Kroese, F.G.; Kok, J.W.; Talaei, F.; Boerema, A.S.; Herwig, A.; Draghiciu, O.; van Buiten, A.; Epema, A.H.; van Dam, A.; Strijkstra, A.M.; Henning, R.H. Low body temperature governs the decline of circulating lymphocytes during hibernation through sphingosine-1-phosphate. Proc. Natl. Acad. Sci. USA, 2011, 108(5), 2052-2057.
30. Piomelli, D.; Giuffrida, A.; Calignano, A.; Rodriguez de Fonseca, F. The endocannabinoid system as a target for therapeutic drugs. Trends Pharmacol. Sci., 2000, 21(6), 218-224.
31. Hayakawa, K.; Mishima, K.; Nozako, M.; Hazekawa, M.; Ogata, A.; Fujioka, M.; Harada, K.; Mishima, S.; Orito, K.; Egashira, N.; Iwasaki, K.; Fujiwara, M. Delta9-tetrahydrocannabinol (Delta9-THC) prevents cerebral infarction via hypothalamic-independent hypothermia. Life Sci., 2007, 80(16), 1466-1471.
32. Rawls, S.M.; Cowan, A.; Tallarida, R.J.; Geller, E.B.; Adler, M.W. Nmethyl-D-aspartate antagonists and WIN 55212-2 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrro lo[3,2,1-i,j]quinolin-6-one], a cannabinoid agonist, interact to produce synergistic hypothermia. J. Pharmacol. Exp. Ther., 2002, 303(1), 395-402.
33. Rawls, S.M.; Cabassa, J.; Geller, E.B.; Adler, M.W. CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenylcarbonyl)-6H-pyrr olo[3,2,1ij]quinolin-6-one]-induced hypothermia. J. Pharmacol. Exp. Ther., 2002, 301(3), 963-968.
34. Gerdeman, G.; Lovinger, D.M. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. J. Neurophysiol., 2001, 85(1), 468-471.
35. Hampson, A.J.; Grimaldi, M. Cannabinoid receptor activation and elevated cyclic AMP reduce glutamate neurotoxicity. Eur. J. Neurosci., 2001, 13(8), 1529-1536.
36. Klein, T.W. Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat. Rev. Immunol., 2005, 5(5), 400-411.
37. Croxford, J.L.; Miller, S.D. Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R+WIN55,212. J. Clin. Invest., 2003, 111(8), 1231-1240.
38. Showalter, V.M.; Compton, D.R.; Martin, B.R.; Abood, M.E. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J. Pharmacol. Exp. Ther., 1996, 278(3), 989-999.
39. Nagayama, T.; Sinor, A.D.; Simon, R.P.; Chen, J.; Graham, S.H.; Jin, K.; Greenberg, D.A. Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J. Neurosci., 1999, 19(8), 2987-2995.
40. Bonfils, P.K.; Reith, J.; Hasseldam, H.; Johansen, F.F. Estimation of the hypothermic component in neuroprotection provided by cannabinoids following cerebral ischemia. Neurochem. Int., 2006, 49(5), 508-518.
41. Leker, R.R.; Gai, N.; Mechoulam, R.; Ovadia, H. Drug-induced hypothermia reduces ischemic damage: effects of the cannabinoid HU-210. Stroke, 2003, 34(8), 2000-2006.
42. Adler, M.W.; Geller, E.B.; Rosow, C.E.; Cochin, J. The opioid system and temperature regulation. Annu. Rev. Pharmacol. Toxicol., 1988, 28, 429-449.
43. Baker, A.K.; Meert, T.F. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice. J. Pharmacol. Exp. Ther., 2002, 302(3), 1253-1264.
44. Spencer, R.L.; Hruby, V.J.; Burks, T.F. Body temperature response profiles for selective mu, delta and kappa opioid agonists in restrained and unrestrained rats. J. Pharmacol. Exp. Ther., 1988, 246(1), 92-101.
45. Handler, C.M.; Geller, E.B.; Adler, M.W. Effect of mu-, kappa-, and delta-selective opioid agonists on thermoregulation in the rat. Pharmacol. Biochem. Behav., 1992, 43(4), 1209-1216.
46. Oeltgen, P.R.; Nilekani, S.P.; Nuchols, P.A.; Spurrier, W.A.; Su, T.P. Further studies on opioids and hibernation: delta opioid receptor ligand selectively induced hibernation in summer-active ground squirrels. Life Sci., 1988, 43(19), 1565-1574.
47. Borlongan, C.V.; Wang, Y.; Su, T.P. Delta opioid peptide (D-Ala 2, DLeu 5) enkephalin: linking hibernation and neuroprotection. Front. Biosci., 2004, 9, 3392-3398.
48. Borlongan, C.V.; Hayashi, T.; Oeltgen, P.R.; Su, T.P.; Wang, Y. Hibernation-like state induced by an opioid peptide protects against experimental stroke. BMC Biol., 2009, 7, 31.
49. Iwata, M.; Inoue, S.; Kawaguchi, M.; Nakamura, M.; Konishi, N.; Furuya, H. Effects of delta-opioid receptor stimulation and inhibition on hippocampal survival in a rat model of forebrain ischaemia. Br. J. Anaesth., 2007, 99(4), 538-546.
50. Duan, Y.L.; Wang, S.Y.; Zeng, Q.W.; Su, D.S.; Li, W.; Wang, X.R.; Zhao, Z. Astroglial reaction to delta opioid peptide [D-Ala2, D-Leu5] enkephalin confers neuroprotection against global ischemia in the adult rat hippocampus. Neuroscience, 2011, 192, 81-90.
51. Gao, C.J.; Li, J.P.; Wang, W.; Lu, B.C.; Niu, L.; Zhu, C.; Wei, Y.Y.; Zhang, T.; Wu, S.X.; Chai, W.; Li, Y.Q. Effects of intracerebroventricular application of the delta opioid receptor agonist [D-Ala2, D-Leu5] enkephalin on neurological recovery following asphyxial cardiac arrest in rats. Neuroscience, 2010, 168(2), 531-542.
52. Su, D.S.; Wang, Z.H.; Zheng, Y.J.; Zhao, Y.H.; Wang, X.R. Dosedependent neuroprotection of delta opioid peptide [D-Ala2, D-Leu5] enkephalin in neuronal death and retarded behavior induced by forebrain ischemia in rats. Neurosci. Lett., 2007, 423(2), 113-117.
53. Zheng, Y.J.; Wang, X.R.; Chen, H.Z.; Wu, X.J.; Zhao, Y.H.; Su, D.S. Protective effects of the delta opioid peptide [d-ala2, d-leu5]enkephalin in an ex vivo model of ischemia/reperfusion in brain slices. CNS Neurosci. Ther., 2012, 18(9), 762-766.
54. Iwata, M.; Inoue, S.; Kawaguchi, M.; Kurita, N.; Horiuchi, T.; Nakamura, M.; Konishi, N.; Furuya, H. Delta opioid receptors stimulation with [D-Ala2, D-Leu5] enkephalin does not provide neuroprotection in the hippocampus in rats subjected to forebrain ischemia. Neurosci. Lett., 2007, 414(3), 242-246.
55. Drabek, T.; Han, F.; Garman, R.H.; Stezoski, J.; Tisherman, S.A.; Stezoski, S.W.; Morhard, R.C.; Kochanek, P.M. Assessment of the delta opioid agonist DADLE in a rat model of lethal hemorrhage treated by emergency preservation and resuscitation. Resuscitation, 2008, 77(2), 220-228.
56. Sigg, D.C.; Coles, J.A., Jr.; Oeltgen, P.R.; Iaizzo, P.A. Role of deltaopioid receptor agonists on infarct size reduction in swine. Am. J. Physiol. Heart Circ. Physiol., 2002, 282(6), H1953-H1960.
57. Shimizu, I.; Iida, T.; Horiuchi, N.; Caterina, M.J. 5-Iodoresiniferatoxin evokes hypothermia in mice and is a partial transient receptor potential vanilloid 1 agonist in vitro. J. Pharmacol. Exp. Ther., 2005, 314(3), 1378-1385.
58. Gavva, N.R.; Bannon, A.W.; Surapaneni, S.; Hovland, D.N. Jr.; Lehto, S.G.; Gore, A.; Juan, T.; Deng, H.; Han, B.; Klionsky, L.; Kuang, R.; Le, A.; Tamir, R.; Wang, J.; Youngblood, B.; Zhu, D.; Norman, M.H.; Magal, E.; Treanor, J.J.; Louis, J.C. The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation. J. Neurosci., 2007, 27(13), 3366-3374.
59. Fosgerau, K.; Ristagno, G.; Jayatissa, M.; Axelsen, M.; Gotfredsen, J.W.; Weber, U.J.; Kober, L.; Torp-Pedersen, C.; Videbaek, C. Increased susceptibility to cardiovascular effects of dihydrocapcaicin in resuscitated rats. Cardiovascular effects of dihydrocapsaicin. BMC Cardiovasc. Disord., 2010, 10, 39.
60. Appendino, G.; De Petrocellis, L.; Trevisani, M.; Minassi, A.; Daddario, N.; Moriello, A.S.; Gazzieri, D.; Ligresti, A.; Campi, B.; Fontana, G.; Pinna, C.; Geppetti, P.; Di Marzo, V. Development of the First Ultra-Potent "Capsaicinoid" Agonist at Transient Receptor Potential Vanilloid Type 1 (TRPV1) Channels and Its Therapeutic Potential. J. Pharmacol. Exper. Therap., 2005, 312(2), 561-570.
61. Muzzi, M.; Felici, R.; Cavone, L.; Gerace, E.; Minassi, A.; Appendino, G.; Moroni, F.; Chiarugi, A. Ischemic neuroprotection by TRPV1 receptor-induced hypothermia. J. Cereb. Blood Flow Metab., 2012, 32(6), 978-982.
62. Chanda, S.; Mould, A.; Esmail, A.; Bley, K. Toxicity studies with pure trans-capsaicin delivered to dogs via intravenous administration. Regul. Toxicol. Pharmacol., 2005, 43(1), 66-75.
63. Kim, S.R.; Chung, Y.C.; Chung, E.S.; Park, K.W.; Won, S.Y.; Bok, E.; Park, E.S.; Jin, B.K. Roles of transient receptor potential vanilloid subtype 1 and cannabinoid type 1 receptors in the brain: neuroprotection versus neurotoxicity. Mol. Neurobiol., 2007, 35(3), 245-254.
64. Shirakawa, H.; Yamaoka, T.; Sanpei, K.; Sasaoka, H.; Nakagawa, T.; Kaneko, S. TRPV1 stimulation triggers apoptotic cell death of rat cortical neurons. Biochem. Biophys. Res. Commun., 2008, 377(4), 1211-1215.
65. Caceda, R.; Kinkead, B.; Nemeroff, C.B. Neurotensin: role in psychiatric and neurological diseases. Peptides, 2006, 27(10), 2385-2404.
66. Bissette, G.; Nemeroff, C.B.; Loosen, P.T.; Prange, A.J., Jr.; Lipton, M.A. Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin. Nature, 1976, 262(5569), 607-609.
67. Granier, C.; van Rietschoten, J.; Kitabgi, P.; Poustis, C.; Freychet, P. Synthesis and characterization of neurotensin analogues for structure/activity relationship studies. Acetyl-neurotensin-(8--13) is the shortest analogue with full binding and pharmacological activities. Eur. J. Biochem., 1982, 124(1), 117-124.
68. Kokko, K.P.; Hadden, M.K.; Price, K.L.; Orwig, K.S.; See, R.E.; Dix, T.A. In vivo behavioral effects of stable, receptor-selective neurotensin[8-13] analogues that cross the blood-brain barrier. Neuropharmacology, 2005, 48(3), 417-425.
69. Cusack, B.; Boules, M.; Tyler, B.M.; Fauq, A.; McCormick, D.J.; Richelson, E. Effects of a novel neurotensin peptide analog given extracranially on CNS behaviors mediated by apomorphine and haloperidol. Brain Res., 2000, 856(1-2), 48-54.
70. Remaury, A.; Vita, N.; Gendreau, S.; Jung, M.; Arnone, M.; Poncelet, M.; Culouscou, J.M.; Le Fur, G.; Soubrie, P.; Caput, D.; Shire, D.; Kopf, M.; Ferrara, P. Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia. Brain Res., 2002, 953(1-2), 63-72.
71. Feifel, D.; Goldenberg, J.; Melendez, G.; Shilling, P.D. The acute and subchronic effects of a brain-penetrating, neurotensin-1 receptor agonist on feeding, body weight and temperature. Neuropharmacology, 2010, 58(1), 195-198.
72. Torup, L.; Borsdal, J.; Sager, T. Neuroprotective effect of the neurotensin analogue JMV-449 in a mouse model of permanent middle cerebral ischaemia. Neurosci. Lett., 2003, 351(3), 173-176.
73. Babcock, A.M.; Baker, D.A.; Hallock, N.L.; Lovec, R.; Lynch, W.C.; Peccia, J.C. Neurotensin-induced hypothermia prevents hippocampal neuronal damage and increased locomotor activity in ischemic gerbils. Brain Res. Bull., 1993, 32(4), 373-378.
74. Tyler-McMahon, B.M.; Boules, M.; Richelson, E. Neurotensin: peptide for the next millennium. Regul. Pept., 2000, 93(1-3), 125-136.
75. Tyler-McMahon, B.M.; Stewart, J.A.; Farinas, F.; McCormick, D.J.; Richelson, E. Highly potent neurotensin analog that causes hypothermia and antinociception. Eur. J. Pharmacol., 2000, 390(1-2), 107-111.
76. Katz, L.M.; Young, A.; Frank, J.E.; Wang, Y.; Park, K. Neurotensininduced hypothermia improves neurologic outcome after hypoxicischemia. Crit. Care Med., 2004, 32(3), 806-810.
77. Smith, K.E.; Boules, M.; Williams, K.; Fauq, A.H.; Richelson, E. The role of NTS2 in the development of tolerance to NT69L in mouse models for hypothermia and thermal analgesia. Behav. Brain Res., 2011, 224(2), 344-349.
78. Scanlan, T.S.; Suchland, K.L.; Hart, M.E.; Chiellini, G.; Huang, Y.; Kruzich, P.J.; Frascarelli, S.; Crossley, D.A.; Bunzow, J.R.; Ronca-Testoni, S.; Lin, E.T.; Hatton, D.; Zucchi, R.; Grandy, D.K., 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nat. Med., 2004, 10(6), 638-642.
79. Bunzow, J.R.; Sonders, M.S.; Arttamangkul, S.; Harrison, L.M.; Zhang, G.; Quigley, D.I.; Darland, T.; Suchland, K.L.; Pasumamula, S.; Kennedy, J.L.; Olson, S.B.; Magenis, R.E.; Amara, S.G.; Grandy, D.K. Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol. Pharmacol., 2001, 60(6), 1181-1188.
80. Klieverik, L.P.; Foppen, E.; Ackermans, M.T.; Serlie, M.J.; Sauerwein, H.P.; Scanlan, T.S.; Grandy, D.K.; Fliers, E.; Kalsbeek, A. Central effects of thyronamines on glucose metabolism in rats. J. Endocrinol., 2009, 201(3), 377-386.
81. Tan, E.S.; Naylor, J.C.; Groban, E.S.; Bunzow, J.R.; Jacobson, M.P.; Grandy, D.K.; Scanlan, T.S. The molecular basis of species-specific ligand activation of trace amine-associated receptor 1 (TAAR(1)). ACS Chem. Biol., 2009, 4(3), 209-220.
82. Panas, H.N.; Lynch, L.J.; Vallender, E.J.; Xie, Z.; Chen, G.L.; Lynn, S.K.; Scanlan, T.S.; Miller, G.M. Normal thermoregulatory responses to 3-iodothyronamine, trace amines and amphetamine-like psychostimulants in trace amine associated receptor 1 knockout mice. J. Neurosci. Res., 2010, 88(9), 1962-1969.
83. Doyle, K.P.; Suchland, K.L.; Ciesielski, T.M.; Lessov, N.S.; Grandy, D.K.; Scanlan, T.S.; Stenzel-Poore, M.P. Novel thyroxine derivatives, thyronamine and 3-iodothyronamine, induce transient hypothermia and marked neuroprotection against stroke injury. Stroke, 2007, 38(9), 2569-2576.
84. Piehl, S.; Hoefig, C.S.; Scanlan, T.S.; Kohrle, J. Thyronamines--past, present, and future. Endocr. Rev., 2010, 32(1), 64-80.
85. Barnett, A.; Goldstein, J.; Taber, R.I. Apomorphine-induced hypothermia in mice; a possible dopaminergic effect. Arch. Int. Pharmacodyn. Ther., 1972, 198(2), 242-247.
86. Costentin, J.; Duterte-Boucher, D.; Panissaud, C.; Michael-Titus, A. Dopamine D1 and D2 receptors mediate opposite effects of apomorphine on the body temperature of reserpinized mice. Neuropharmacology, 1990, 29(1), 31-35.
87. Sanchez, C. The effects of dopamine D-1 and D-2 receptor agonists on body temperature in male mice. Eur. J. Pharmacol., 1989, 171(2-3), 201-206.
88. Salmi, P.; Jimenez, P.; Ahlenius, S. Evidence for specific involvement of dopamine D1 and D2 receptors in the regulation of body temperature in the rat. Eur. J. Pharmacol., 1993, 236(3), 395-400.
89. Meller, E.; Hizami, R.; Kreuter, L. Hypothermia in mice: D2 dopamine receptor mediation and absence of spare receptors. Pharmacol. Biochem. Behav., 1989, 32(1), 141-145.
90. Zarrindast, M.R.; Mahmoudi, M. Bromocriptine-induced hypothermia: D-2 receptor involvement. Arch. Int. Pharmacodyn. Ther., 1989, 298, 38-49.
91. Verma, A.; Kulkarni, S.K. Dopamine receptor mediated hypothermic action of B-HT 920 in rats. J. Pharm. Pharmacol., 1991, 43(6), 421-424.
92. Millan, M.J.; Audinot, V.; Melon, C.; Newman-Tancredi, A. Evidence that dopamine D3 receptors participate in clozapine-induced hypothermia. Eur. J. Pharmacol., 1995, 280(2), 225-229.
93. Millan, M.J.; Peglion, J.L.; Vian, J.; Rivet, J.M.; Brocco, M.; Gobert, A.; Newman-Tancredi, A.; Dacquet, C.; Bervoets, K.; Girardon, S. et al. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist(+)-S 14297: 1. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin secretion and catalepsy. J. Pharmacol. Exp. Ther., 1995, 275(2), 885-898.
94. Johansen, F.F.; Jorgensen, H.S.; Reith, J. Prolonged drug-induced hypothermia in experimental stroke. J. Stroke Cerebrovasc. Dis., 2003, 12(2), 97-102.
95. Liu, X.H.; Kato, H.; Chen, T.; Kato, K.; Itoyama, Y. Bromocriptine protects against delayed neuronal death of hippocampal neurons following cerebral ischemia in the gerbil. J. Neurol. Sci., 1995, 129(1), 9-14.
96. O'Neill, M.J.; Hicks, C.A.; Ward, M.A.; Cardwell, G.P.; Reymann, J.-M.; Allain, H.; Bentué-Ferrer, D. Dopamine D2 receptor agonists protect against ischaemia-induced hippocampal neurodegeneration in global cerebral ischaemia. Eur. J. Pharmacol., 1998, 352(1), 37-46.
97. Wagner, F.; Asfar, P.; Calzia, E.; Radermacher, P.; Szabo, C. Bench-tobedside review: Hydrogen sulfide--the third gaseous transmitter: applications for critical care. Crit. Care, 2009, 13(3), 213.
98. Khan, A.A.; Schuler, M.M.; Prior, M.G.; Yong, S.; Coppock, R.W.; Florence, L.Z.; Lillie, L.E. Effects of hydrogen sulfide exposure on lung mitochondrial respiratory chain enzymes in rats. Toxicol. Appl. Pharmacol., 1990, 103(3), 482-490.
99. Dorman, D.C.; Moulin, F.J.; McManus, B.E.; Mahle, K.C.; James, R.A.; Struve, M.F. Cytochrome oxidase inhibition induced by acute hydrogen sulfide inhalation: correlation with tissue sulfide concentrations in the rat brain, liver, lung, and nasal epithelium. Toxicol. Sci., 2002, 65(1), 18-25.
100. Blackstone, E.; Morrison, M.; Roth, M.B. H2S induces a suspended animation-like state in mice. Science, 2005, 308(5721), 518.
101. Volpato, G.P.; Searles, R.; Yu, B.; Scherrer-Crosbie, M.; Bloch, K.D.; Ichinose, F.; Zapol, W.M. Inhaled hydrogen sulfide: a rapidly reversible inhibitor of cardiac and metabolic function in the mouse. Anesthesiology, 2008, 108(4), 659-668.
102. Blackstone, E.; Roth, M.B. Suspended animation-like state protects mice from lethal hypoxia. Shock, 2007, 27(4), 370-372.
103. Joseph, C.; Buga, A.-M.; Vintilescu, R.; Balseanu, A.T.; Moldovan, M.; Junker, H.; Walker, L.; Lotze, M.; Popa-Wagner, A. Prolonged gaseous hypothermia prevents the upregulation of phagocytosis-specific protein Annexin 1 and causes low-amplitude EEG activity in the aged rat brain after cerebral ischemia. J. Cereb. Blood Flow Metab., 2012, 32(8), 1632-1642.
104. Florian, B.; Vintilescu, R.; Balseanu, A.T.; Buga, A.-M.; Grisk, O.; Walker, L.C.; Kessler, C.; Popa-Wagner, A. Long-term hypothermia reduces infarct volume in aged rats after focal ischemia. Neurosci. Lett., 2008, 438(2), 180-185.
105. Joseph, C.; Buga, A.M.; Vintilescu, R.; Balseanu, A.T.; Moldovan, M.; Junker, H.; Walker, L.; Lotze, M.; Popa-Wagner, A. Prolonged gaseous hypothermia prevents the upregulation of phagocytosis-specific protein Annexin 1 and causes low-amplitude EEG activity in the aged rat brain after cerebral ischemia. J. Cereb. Blood Flow Metab., 2012, 32(8), 1632-1642.
106. Qu, K.; Chen, C.P.; Halliwell, B.; Moore, P.K.; Wong, P.T. Hydrogen sulfide is a mediator of cerebral ischemic damage. Stroke, 2006, 37(3), 889-893.
107. Pan, Y.; Zhang, H.; VanDeripe, D.R.; Cruz-Flores, S.; Panneton, W.M. Heliox and oxygen reduce infarct volume in a rat model of focal ischemia. Exp. Neurol., 2007, 205(2), 587-590.
108. Gruss, M.; Bushell, T.J.; Bright, D.P.; Lieb, W.R.; Mathie, A.; Franks, N.P. Two-pore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol. Pharmacol., 2004, 65(2), 443-452.
109. Hobbs, C.; Thoresen, M.; Tucker, A.; Aquilina, K.; Chakkarapani, E.; Dingley, J. Xenon and hypothermia combine additively, offering longterm functional and histopathologic neuroprotection after neonatal hypoxia/ischemia. Stroke, 2008, 39(4), 1307-1313.
110. Hess, D.R.; Fink, J.B.; Venkataraman, S.T.; Kim, I.K.; Myers, T.R.; Tano, B.D. The history and physics of heliox. Respir. Care, 2006, 51(6), 608-612.
111. Tapper, D.; Arensman, R.; Johnson, C.; Folkman, J. The effect of helium-oxygen mixtures on body temperature. J. Pediatr. Surg., 1974, 9(5), 597-603.
112. David, H.N.; Haelewyn, B.; Chazalviel, L.; Lecocq, M.; Degoulet, M.; Risso, J.J.; Abraini, J.H. Post-ischemic helium provides neuroprotection in rats subjected to middle cerebral artery occlusion-induced ischemia by producing hypothermia. J. Cereb. Blood Flow Metab., 2009, 29(6), 1159-1165.
113. Pan, Y.; Zhang, H.; Acharya, A.B.; Cruz-Flores, S.; Panneton, W.M. The effect of heliox treatment in a rat model of focal transient cerebral ischemia. Neurosci. Lett., 2011, 497(2), 144-147.
114. Ikeda, T.; Sessler, D.I.; Kikura, M.; Kazama, T.; Ikeda, K.; Sato, S. Less Core Hypothermia when Anesthesia Is Induced with Inhaled Sevoflurane Than with Intravenous Propofol. Anesthesia Analges.,1999, 88(4), 921.
115. Guzel, O.; Inal, G.; Cirakli, Z.T.; Eraslan, E.; Aktas, M. Effects of propofol and sevoflurane anesthesia on some physiological and biochemical parameters in rabbits. Med. Weter., 2006, 62(12), 1383-1386.
116. Adamczyk, S.; Robin, E.; Simerabet, M.; Kipnis, E.; Tavernier, B.; Vallet, B.; Bordet, R.; Lebuffe, G. Sevoflurane pre-and postconditioning protect the brain via the mitochondrial KATP channel. Br. J. Anaesthes., 2010, 104(2), 191-200.
117. Lee, J.J.; Li, L.; Jung, H.H.; Zuo, Z. Postconditioning with isoflurane reduced ischemia-induced brain injury in rats. Anesthesiology, 2008, 108(6), 1055-1062.
118. Mehta, A.K.; Kulkarni, S.K. Effect of purinergic substances on rectal temperature in mice: involvement of P1-purinoceptors. Arch. Int. Pharmacodyn. Ther., 1983, 264(2), 180-186.
119. Swoap, S.J.; Rathvon, M.; Gutilla, M. AMP does not induce torpor. Am. J. Physiol. Regulat. Integr. Comparat. Physiol., 2007, 293(1), R468-R473.
120. Iliff, B.W.; Swoap, S.J. Central adenosine receptor signaling is necessary for daily torpor in mice. Am. J. Physiol. Regulat. Integr. Compar. Physiol., 2012, 303(5), R477-R484.
121. Anderson, R.; Sheehan, M.J.; Strong, P. Characterization of the adenosine receptors mediating hypothermia in the conscious mouse. Br. J. Pharmacol., 1994, 113(4), 1386-1390.
122. Schubert, P.; Kreutzberg, G.W. Cerebral protection by adenosine. Acta Neurochir. Suppl. (Wien.), 1993, 57, 80-88.
123. Sweeney, M.I. Neuroprotective Effects of Adenosine in Cerebral Ischemia: Window of Opportunity. Neurosci. Biobehav. Rev., 1997, 21(2), 207-217.
124. Cunha, R.A. Neuroprotection by adenosine in the brain: From A(1) receptor activation to A (2A) receptor blockade. Purinergic Signal, 2005, 1(2), 111-134.
125. Zhang, J.; Kaasik, K.; Blackburn, M.R.; Lee, C.C. Constant darkness is a circadian metabolic signal in mammals. Nature, 2006, 439(7074), 340-343.
126. Zhang, F.; Wang, S.; Luo, Y.; Ji, X.; Nemoto, E.M.; Chen, J. When hypothermia meets hypotension and hyperglycemia: the diverse effects of adenosine 5'-monophosphate on cerebral ischemia in rats. J. Cereb. Blood Flow Metab., 2009, 29(5), 1022-1034.
127. Zhang, M.; Li, W.; Niu, G.; Leak, R.K.; Chen, J.; Zhang, F. ATP induces mild hypothermia in rats but has a strikingly detrimental impact on focal cerebral ischemia. J. Cereb. Blood Flow Metab., 2013, 33(1), e1-e10.
128. Freireich, E.J.; Gehan, E.A.; Rall, D.P.; Schmidt, L.H.; Skipper, H.E. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother. Rep., 1966, 50(4), 219-244.
129. Wang, S.; Duan, Y.; Su, D.; Li, W.; Tan, J.; Yang, D.; Wang, W.; Zhao, Z.; Wang, X. Delta opioid peptide [D-Ala2, D-Leu5] enkephalin (DADLE) triggers postconditioning against transient forebrain ischemia. Eur. J. Pharmacol., 2011, 658(2-3), 140-144.
130. Tao, Z.; Zhao, Z.; Lee, C.C., 5'-Adenosine monophosphate induced hypothermia reduces early stage myocardial ischemia/reperfusion injury in a mouse model. Am. J. Transl. Res., 2011, 3(4), 351-361.
131. Hacke, W.; Kaste, M.; Bluhmki, E.; Brozman, M.; Davalos, A.; Guidetti, D.; Larrue, V.; Lees, K.R.; Medeghri, Z.; Machnig, T.; Schneider, D.; von Kummer, R.; Wahlgren, N.; Toni, D. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med., 2008, 359(13), 1317-1329.
132. Sandercock, P.; Wardlaw, J.M.; Lindley, R.I.; Dennis, M.; Cohen, G.; Murray, G.; Innes, K.; Venables, G.; Czlonkowska, A.; Kobayashi, A.; Ricci, S.; Murray, V.; Berge, E.; Slot, K.B.; Hankey, G.J.; Correia, M.; Peeters, A.; Matz, K.; Lyrer, P.; Gubitz, G.; Phillips, S.J.; Arauz, A. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet, 2012, 379(9834), 2352-2363.